Skip to content

Effect of Sho-saiko-to-ka-kikyo-sekko, a Kampo Medicine, on Patients with Acute Pharyngitis and Tonsillitis

Effect of Sho-saiko-to-ka-kikyo-sekko, a Kampo Medicine, on Patients with Acute Pharyngitis and Tonsillitis: A Randomized Controlled Study - Effect of Sho-saiko-to-ka-kikyo-sekko on acute pharyngitis and tonsillitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017822
Enrollment
54
Registered
2015-06-05
Start date
2015-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pharyngitis, acute tonsillitis

Interventions

Patients take one pack (2.5g/p) of Sho-saiko-to-ka-kikyo-sekko, Kampo medicine (TJ-109), three times a day, after gurgling by dissolving in a cup of warm water. Patients take one pack (1.0g/p) of PL

Sponsors

Department of General medicine Juntendo university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From June 2015 to October 2020, patients of acute pharyngitis and tonsillitis who visited a department of general medicine Juntendo university school of medicine and accepted to participate in this study were registered.

Exclusion criteria

Exclusion criteria: 1) Patients of peritonsillar abscess 2) Patients with positive for rapid antigen streptococcus test 3) Patients who meet four Centor criteria 4) Flu patients 5) Pregnant patients and Breast-feeding patients

Design outcomes

Primary

MeasureTime frame
Primary outcome is the evaluation of sore throat with four phases for five days after taking Sho-saiko-to-ka-kikyo-sekko, and to compare with the conventional treatment group.

Secondary

MeasureTime frame
Secondary outcomes are the evaluation of fever, headache, fatigue and appetite loss and dizziness with four phases for five days after taking Sho-saiko-to-ka-kikyo-sekko, and to compare with the conventional treatment group.

Countries

Japan

Contacts

Public ContactYukiko Fukui

Juntendo university school of medicine Department of General medicine

yukiko-w@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026